Información de IDEXX Laboratories Inc, dividendo de IDEXX Laboratories Inc, actividades de los accionistas y más

Más Datos de IDEXX Laboratories Inc Compañía

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Información de IDEXX Laboratories Inc



Símbolo de cotizaciónIDXX

Nombre de la empresaIDEXX Laboratories Inc

Fecha de salida a bolsaJun 21, 1991

Director ejecutivoEmerson (Andrew)

Número de empleados11000

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 21

DirecciónOne Idexx Drive

CiudadWESTBROOK

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal04092-2041

Teléfono12075560300

Sitio Webhttps://www.idexx.com/

Símbolo de cotizaciónIDXX

Fecha de salida a bolsaJun 21, 1991

Director ejecutivoEmerson (Andrew)

Ejecutivos de IDEXX Laboratories Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

8.25K

-3.84%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

--

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.17K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.89K

+2.86%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

4.16K

-0.46%

Mr. Daniel M. (Dan) Junius

Independent Director

3.10K

+3.00%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

3.00K

+36.06%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Ms. Irene Chang Britt

Independent Director

208.00

--

Ms. Karen Peacock

Independent Director

1.00

--

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

8.25K

-3.84%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

--

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.17K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.89K

+2.86%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

4.16K

-0.46%

Mr. Daniel M. (Dan) Junius

Independent Director

3.10K

+3.00%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

CAG Diagnostics recurring revenue

3.41B

79.17%

IDEXX VetLab consumables

1.50B

34.78%

Reference laboratory diagnostic and consulting services

1.42B

33.09%

Rapid assay products

348.95M

8.11%

CAG Diagnostics capital - instruments

345.88M

8.04%

Otro

-2.72B

-63.18%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

2.75B

63.96%

Other Euorpe

230.03M

5.34%

Germany

206.76M

4.80%

Canada

167.32M

3.89%

United Kingdom

154.44M

3.59%

Otro

792.37M

18.41%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

CAG Diagnostics recurring revenue

3.41B

79.17%

IDEXX VetLab consumables

1.50B

34.78%

Reference laboratory diagnostic and consulting services

1.42B

33.09%

Rapid assay products

348.95M

8.11%

CAG Diagnostics capital - instruments

345.88M

8.04%

Otro

-2.72B

-63.18%

Estadísticas de accionistas

Actualizado: hace 7 horas

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

6.79%

Vanguard Capital Management, LLC

6.57%

Vanguard Portfolio Management, LLC

4.96%

State Street Investment Management (US)

4.64%

Geode Capital Management, L.L.C.

3.28%

Otro

73.77%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

6.79%

Vanguard Capital Management, LLC

6.57%

Vanguard Portfolio Management, LLC

4.96%

State Street Investment Management (US)

4.64%

Geode Capital Management, L.L.C.

3.28%

Otro

73.77%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

54.08%

Investment Advisor/Hedge Fund

31.62%

Research Firm

3.69%

Pension Fund

3.67%

Bank and Trust

1.77%

Hedge Fund

0.74%

Individual Investor

0.70%

Sovereign Wealth Fund

0.69%

Family Office

0.48%

Otro

2.56%

Participación institucional



Actualizado: dom., 5 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q1

2458

76.16M

96.54%

-2.09M

2025Q4

2411

81.21M

101.70%

-691.60K

2025Q3

2319

77.76M

97.19%

-4.03M

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

5.36M

6.74%

+116.07K

+2.22%

Dec 31, 2025

State Street Investment Management (US)

3.66M

4.6%

+138.96K

+3.95%

Dec 31, 2025

Geode Capital Management, L.L.C.

2.58M

3.25%

+86.26K

+3.45%

Dec 31, 2025

Fundsmith LLP

1.88M

2.36%

-734.42K

-28.13%

Dec 31, 2025

Baron Capital Management, Inc.

1.80M

2.26%

-86.09K

-4.57%

Dec 31, 2025

Invesco Capital Management (QQQ Trust)

1.70M

2.14%

-41.26K

-2.37%

Feb 28, 2026

BlackRock Asset Management Ireland Limited

996.39K

1.25%

-2.29K

-0.23%

Dec 31, 2025

Polen Capital Management, LLC

960.54K

1.21%

-166.61K

-14.78%

Dec 31, 2025

ETFs relacionados



Actualizado: mar., 2 de dic

Nombre

Proporción

ProShares Pet Care ETF

9.4%

iShares U.S. Medical Devices ETF

4.42%

First Trust Water ETF

3.98%

SMI 3Fourteen Full-Cycle Trend ETF

3.9%

Nuveen ESG Mid-Cap Growth ETF

3.47%

Adaptive Core ETF

2.61%

First Trust S&P 500 Economic Moat Index ETF

2.25%

Acruence Active Hedge US Equity ETF

2.18%

Tema Durable Quality ETF

2.1%

Putnam Sustainable Future ETF

2.03%

ProShares Pet Care ETF

Proporción9.4%

iShares U.S. Medical Devices ETF

Proporción4.42%

First Trust Water ETF

Proporción3.98%

SMI 3Fourteen Full-Cycle Trend ETF

Proporción3.9%

Nuveen ESG Mid-Cap Growth ETF

Proporción3.47%

Adaptive Core ETF

Proporción2.61%

First Trust S&P 500 Economic Moat Index ETF

Proporción2.25%

Acruence Active Hedge US Equity ETF

Proporción2.18%

Tema Durable Quality ETF

Proporción2.1%

Putnam Sustainable Future ETF

Proporción2.03%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos